ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
April 24, 2018 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, April 24, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has entered into a $250,000 initial sales agreement with Vage Nigeria Ltd....
ViaDerma, Inc. Provides an Update of Current and Future Product Sales
April 02, 2018 08:20 ET
|
ViaDerma, Inc.
LOS ANGELES, April 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide a update on current sales of the Company’s flagship product, Vitastem. ViaDerma...
ViaDerma, Inc. Provides an Update of Current Marketing Activities
March 08, 2018 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), is pleased to provide an update of the Company’s current marketing activities: ViaDerma is in discussions with a...
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
March 02, 2018 09:15 ET
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled...
ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in US District Federal Court
February 07, 2018 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Feb. 07, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), recently announced the complaint filed by Steven J. Keough in a South Dakota Federal Court, has been dismissed without...
ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis
March 02, 2015 09:17 ET
|
ViaDerma Licensing
LOS ANGELES, March 2, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM) (The Company), a specialty pharmaceutical company devoted to bringing new products to market, is excited to start...
ViaDerma, Inc. Announces Preston Richards to Join Advisory Board
January 22, 2015 09:01 ET
|
ViaDerma Licensing
LOS ANGELES, Jan. 22, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a developer of advanced topical pharmaceuticals, is pleased to announce the addition of Preston Richards to their Advisory...
ViaDerma, Inc. Launches New Website
January 13, 2015 09:01 ET
|
ViaDerma Licensing
LOS ANGELES, Jan. 13, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to bringing new products to the market, is excited to officially announce its new...
TetraStem(TM) Antibiotic Continues to Demonstrate Treatment Success Leading Management to Explore Partnerships With Big Pharmaceutical Companies
December 09, 2014 09:44 ET
|
ViaDerma Licensing
LOS ANGELES, Dec. 9, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced TetraStemTM, a topical liquid...
ViaDerma, Inc. Lead Product TetraStem Shows Promise in Treating Acne
November 21, 2014 10:16 ET
|
ViaDerma Licensing
LOS ANGELES, Nov. 21, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new...